Reduced blood flow through intrapulmonary arteriovenous anastomoses at rest and during exercise in lowlanders during acclimatization to high altitude by Boulet, Lindsey M et al.
Experimental Physiology
https://ep.msubmit.net
EP-RP-2016-086182R1
Title: Reduced blood flow through intrapulmonary arteriovenous anastomoses at rest
and during exercise in lowlanders during acclimatization to high altitude.
Authors: Lindsey M. Boulet
Andrew T Lovering
Michael M Tymko
Trevor A. Day
Mike Stembridge
Trang Anh Nguyen
Philip N Ainslie
Glen E Foster
Author Conflict: No competing interests declared 
Running Title: Exercise-induced intrapulmonary shunt at altitude
Abstract: Blood flow through intrapulmonary arteriovenous anastomoses (Q̇IPAVA) is
elevated during exercise at sea level (SL) and at rest in acute normobaric hypoxia.
Following high altitude (HA) acclimatization, resting Q̇IPAVA is similar to SL, but it is
unknown if this is true during exercise at HA. We hypothesized that exercise at HA
(5,050 m) would exacerbate Q̇IPAVA due to heightened pulmonary arterial pressure.
Using a supine cycle ergometer, seven healthy adults free from intracardiac shunts
underwent an incremental exercise test at SL (25, 50, 75% of SL V̇O2peak) and at
HA (25, 50% of SL V̇O2peak). Echocardiography was used to determine cardiac
output (Q̇) and pulmonary artery systolic pressure (PASP) and agitated saline
contrast was used to determine Q̇IPAVA (bubble score; 0-5). The principle findings
were: (1) Q̇ was similar at SL-rest (3.9 {plus minus} 0.47 l min-1) compared to HA-
Disclaimer: This is a confidential document.
rest (4.5 {plus minus} 0.49 l min-1; P=0.382), but increased from rest during both SL
and HA exercise (P<0.001); (2) PASP increased from SL-rest (19.2 {plus minus} 0.7
mmHg) to HA-rest (33.7 {plus minus} 2.8 mmHg; P=0.001) and, compared to SL,
PASP was elevated during HA exercise (P=0.003); (3) Q̇IPAVA was increased from
SL-rest (0) to HA-rest (median=1; P=0.04) and increased from resting values during
SL exercise (P<0.05), but were unchanged during HA exercise (P=0.91), despite
significant increases in Q̇ and PASP. Theoretical modeling of microbubble dissolution
suggests that the lack of Q̇IPAVA in response to exercise at HA is unlikely caused by
saline contrast instability.
New Findings: What is the central question of this study? To determine whether
exercise following 4-7 days at 5,050 m would augment blood flow through
intrapulmonary arteriovenous anastomoses (Q̇IPAVA) compared to sea level exercise
using the technique of agitated saline contrast echocardiography. What is the main
finding and its importance? Despite a significant increase in both cardiac output and
pulmonary pressure during exercise at high altitude, there is very little Q̇IPAVA at rest
or during exercise following 4-7 days of acclimatization. Mathematical modeling
suggests bubble instability at high altitude is an unlikely explanation for the reduced
Q̇IPAVA.
Dual Publication: No 
Funding: Gouvernement du Canada | Natural Sciences and Engineering Research
Council of Canada (Conseil de Recherches en Sciences Naturelles et en Génie du
Canada): Glen E Foster, 2014-05643
Disclaimer: This is a confidential document.
Title: Reduced blood flow through intrapulmonary arteriovenous 
anastomoses at rest and during exercise in lowlanders during 
acclimatization to high altitude. 
 
Authors: Lindsey M. Boulet1 
 Andrew T. Lovering2 
Michael M. Tymko1 
Trevor A. Day3 
 Mike Stembridge4 
 Trang Anh Nguyen1,5  
 Philip N. Ainslie1 
 Glen E. Foster1 
 
Affiliations: 1Centre for Heart, Lung, and Vascular Health, School of Health 
and Exercise Science, University of British Columbia, Kelowna, 
Canada. 
2Department of Human Physiology, University of Oregon, Eugene, 
USA. 
 3Department of Biology, Faculty of Science and Technology, 
Mount Royal University, Calgary, Alberta, Canada. 
 4Cardiff School of Sport, Cardiff Metropolitan University, Cardiff, 
UK. 
 5Department of Biomedical Engineering, International University, 
Vietnam National University, Ho Chi Minh City, Vietnam 
 
Correspondence: Glen E. Foster, PhD. 
School of Health and Exercise Science 
Faculty of Health and Social Development 
University of British Columbia 
1147 Research Rd. 
Kelowna, BC, V1V 1V7 
 
Telephone: 250-807-8224 
Fax: 250-807-9665 
Email: glen.foster@ubc.ca 
 
Running head:  Exercise-induced intrapulmonary shunt at altitude 
 
Intrapulmonary Shunt at Altitude 
 
 
 
2
NEW FINDINGS 
• What is the central question of this study? To determine whether exercise 
following 4-7 days at 5,050 m would augment blood flow through intrapulmonary 
arteriovenous anastomoses (Q̇IPAVA) compared to sea level exercise using the 
technique of agitated saline contrast echocardiography. 
 
• What is the main finding and its importance? Despite a significant increase in 
both cardiac output and pulmonary pressure during exercise at high altitude, there 
is very little Q̇IPAVA at rest or during exercise following 4-7 days of 
acclimatization.  Mathematical modeling suggests bubble instability at high 
altitude is an unlikely explanation for the reduced Q̇IPAVA.  
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ABSTRACT 
Blood flow through intrapulmonary arteriovenous anastomoses (Q̇IPAVA) is elevated 
during exercise at sea level (SL) and at rest in acute normobaric hypoxia.  Following high 
altitude (HA) acclimatization, resting Q̇IPAVA is similar to SL, but it is unknown if this is 
true during exercise at HA.  We hypothesized that exercise at HA (5,050 m) would 
exacerbate Q̇IPAVA due to heightened pulmonary arterial pressure.  Using a supine cycle 
ergometer, seven healthy adults free from intracardiac shunts underwent an incremental 
exercise test at SL (25, 50, 75% of SL V̇O2peak) and at HA (25, 50% of SL V̇O2peak).  
Echocardiography was used to determine cardiac output (Q̇) and pulmonary artery 
systolic pressure (PASP) and agitated saline contrast was used to determine Q̇IPAVA 
(bubble score; 0-5).  The principle findings were: (1) Q̇ was similar at SL-rest (3.9 ± 0.47 
l min-1) compared to HA-rest (4.5 ± 0.49 l min-1; P=0.382), but increased from rest during 
both SL and HA exercise (P<0.001); (2) PASP increased from SL-rest (19.2 ± 0.7 
mmHg) to HA-rest (33.7 ± 2.8 mmHg; P=0.001) and, compared to SL, PASP was 
elevated during HA exercise (P=0.003); (3) Q̇IPAVA was increased from SL-rest (0) to 
HA-rest (median=1; P=0.04) and increased from resting values during SL exercise 
(P<0.05), but were unchanged during HA exercise (P=0.91), despite significant increases 
in Q̇ and PASP.  Theoretical modeling of microbubble dissolution suggests that the lack 
of Q̇IPAVA in response to exercise at HA is unlikely caused by saline contrast instability. 
 
Key words: intrapulmonary arteriovenous anastomoses, exercise, high altitude, and 
contrast dissolution. 
 
  
Intrapulmonary Shunt at Altitude 
 
 
 
4
INTRODUCTION 
Intrapulmonary arteriovenous anastomoses (IPAVA) are present throughout the lung in 
many mammals including humans and range in size from 25-500 μm (Lovering et al. 
2007; Tobin, 1966).  Though the pulmonary circulation facilitates gas exchange between 
the blood and alveoli, blood flow through IPAVA (Q̇IPAVA) is believed to bypass sites of 
gas exchange hindering pulmonary gas exchange efficiency (Stickland et al. 2004).  
Q̇IPAVA is normally assessed using the technique of agitated saline contrast 
echocardiography in participants negative for intracardiac shunts and without pulmonary 
arteriovenous malformations (Lovering & Goodman, 2012).  In these individuals, Q̇IPAVA 
increases in an exercise-intensity dependent manner (Eldridge et al. 2004; Elliott et al. 
2014b; Norris et al. 2014) and is exacerbated with acute normobaric hypoxia (Lovering et 
al. 2008b).  For example, Q̇IPAVA is non-detectable at rest in most healthy humans at both 
sea level (SL) (Elliott et al. 2013) and high altitude (HA) (Foster et al. 2014), but is 
present in >90% of participants during normoxic exercise and increases to 100% during 
hypoxic exercise (Elliott et al. 2011; Lovering et al. 2008b).  Given this interaction 
between exercise intensity and hypoxia it seems logical that Q̇IPAVA would be exacerbated 
when exercising at HA.  
The primary purpose of the current study was to determine if Q̇IPAVA is increased 
during exercise while acclimatizing to 5,050 m.  Interestingly, previous reports have 
shown that Q̇IPAVA is minimized during exercise when hyperoxia [fraction of inspired O2 
(FIO2) = 1.0] is administered (Lovering et al. 2008a).  Therefore, the secondary purpose 
of this study was to identify if hyperoxia regulates Q̇IPAVA during exercise at HA similar 
to sea-level reports.  Finally, we conducted theoretical modeling and previously reported 
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bubble diameter distributions at SL to estimate the impact of HA on saline contrast 
stability (Feinstein et al. 1984; Vuille et al. 1994).  We hypothesized that Q̇IPAVA would 
be greater during exercise at HA compared to similar workloads at SL and hyperoxia 
would reduce Q̇IPAVA.  We also hypothesized that the effect of HA on contrast stability 
would be negligible across the transit times expected during exercise from point of 
injection to detection in the left ventricle. 
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MATERIALS AND METHODS 
All experimental procedures and protocols were submitted to, and approved by the 
Clinical Research Ethics Board at the University of British Columbia and the Nepal 
Health Research Council, and conformed to the Canadian Government Tri-Council 
Policy Statement for research involving humans and the Declaration of Helsinki.  All 
participants provided written informed consent prior to participation in this study.  This 
study was part of a larger research expedition conducted in April-June in 2012 (Foster et 
al. 2014; Lewis et al. 2014; Smirl et al. 2014; Smith et al., 2014; Stembridge et al. 2015; 
Willie et al. 2014; Willie et al. 2015).  As such, participants took part in a number of 
studies conducted in Kelowna, BC (344 m) and during three weeks at the Ev-K2-CNR 
Pyramid Laboratory located near Mt. Everest base camp at 5,050 m.  Participants 
involved in this study had a minimum of 48 hours between studies to mitigate any 
concern of cross-contamination from pharmaceutical interventions. 
 
Participants.  
17 healthy participants volunteered for this study and were tested in Kelowna, British 
Columbia, Canada near SL (elevation = 344m).  From this group of volunteers, seven 
(age = 33.1 ± 7.8 yrs; one female) were negative for a patent foramen ovale (PFO-) based 
upon transthoracic agitated saline contrast echocardiography (Marriott et al. 2013).  Since 
the purpose of this study was to determine Q̇IPAVA, participants were excluded if they had 
a PFO at rest or with a provocative maneuver (see Agitated Saline Contrast 
Echocardiography).  These seven participants were studied at SL and HA.  All 
participants studied met the inclusion criteria including 18-49 years of age, non-smoking, 
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and free from any known history of neurological, respiratory and cardiovascular diseases.  
Participants were asked to refrain from caffeine, alcohol and vigorous exercise at least 12 
hours prior to experimentation.  Participants were not born at altitudes >1,200 m and had 
not travelled to HA (>2,500m) within six months prior to SL testing.  In addition, 
participants were excluded if they were hypertensive (>140/90 mmHg), had poor 
pulmonary function as determined by spirometry (i.e. forced expiratory volume in 
1s/forced vital capacity < 0.75), or did not present with tricuspid regurgitation for the 
estimation of pulmonary artery systolic pressure (PASP).  The results presented, unless 
otherwise specified, are based on seven participants. 
 
Experimental Protocol.  
Participants were studied on three separate occasions.  First, participants attended the 
laboratory in Kelowna and were assessed for inclusion/exclusion criteria and completed 
an incremental exercise test to exhaustion (see specific methods below).  Height and 
weight were measured and spirometry (Vmax Spectra 20, Sensormedics, Yorba Linda, 
California) was conducted in accordance with the standards outlined by the American 
Thoracic Society and the European Respiratory Society (Miller et al. 2005).  Participants 
returned within one week to complete the SL submaximal exercise protocol.  During this 
visit, participants were instrumented with an intravenous catheter at the antecubital fossa 
while resting supine on a hospital bed.  Participants were then asked to lie in the supine 
position on a custom built, supine cycle ergometer.  Following 5 minutes of rest, the 
participant was positioned in the left lateral decubitus position and, three consecutive 
blood pressure measurements were manually obtained from the right upper arm using a 
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sphygmomanometer and stethoscope for auscultation of Korotkoff sounds.  Also, at this 
time, peripheral arterial oxyhaemoglobin saturation (SpO2; Model 3100, WristOx, Nonin 
Medical Inc., MN, USA) was estimated by pulse oximetry of the right index finger.  Next 
baseline images were collected for stroke volume (SV; ml), cardiac output (Q̇; l min-1) 
and pulmonary artery systolic pressure (PASP; mmHg) by echocardiography.  HR was 
measured by standard lead two electrocardiogram.  Next, an apical 4-chamber view of the 
heart was acquired and Q̇IPAVA was determined by the technique of agitated saline 
contrast echocardiography.  These experimental measurements were repeated during 
submaximal exercise stages (5 min each) equivalent to 25, 50, and 75% of SL V̇O2peak.  
Following the 75% V̇O2peak submaximal exercise stage at SL, participants were given a 
10 minute period of rest and then the stage was repeated while the participant was 
administered hyperoxic gas (FIO2 = 0.5). The FIO2 used to test hyperoxic reversibility of 
Q̇IPAVA at SL (0.5) and HA (1.0) were selected to match a similar inspired PO2 of 
approximately 350 mmHg.  
 Participants then travelled to Kathmandu, Nepal (1,400 m), and following a week 
in Kathmandu, underwent an 8-10 day trek to the Ev-K2-CNR Pyramid Laboratory 
located at 5,050 m in the Himalayan Mountains in Nepal under prophylactic 
acetazolamide administration (125 mg 2x per day).  Acetazolamide was discontinued 24 
hours prior to ascending from Pheriche (4,300 m) to the laboratory (5,050 m).  Four-to-
seven days after arrival at 5,050 m participants conducted two submaximal exercise 
stages corresponding to 25 and 50% of SL V̇O2peak.  Following the last stage of exercise, 
participants rested for 10 minutes prior to repeating the final stage in hyperoxic gas (FIO2 
= 1.0).  
Intrapulmonary Shunt at Altitude 
 
 
 
9
  
Measurements. 
Maximal Exercise Testing.  Using a custom built, supine cycle ergometer, participants 
underwent an incremental exercise test to exhaustion in normoxia to obtain relative peak 
power outputs at SL.  The maximal exercise protocol was developed for individual 
participants to reach their maximum workload capacity in approximately 6-8 minutes.  
The protocol began at 50 watts and workload increased by 50 watts every minute until 
participants reached volitional exhaustion.  During the maximal exercise protocol expired 
gas was analyzed for minute ventilation (V̇E), O2 uptake (V̇O2), CO2 production (V̇CO2), 
and the respiratory exchange ratio (RER) (Vmax 29C, SensorMedics, Yorba Linda, CA), 
and heart rate was determined by electrocardiograph (CardioSoft, GE Healthcare, 
Waukesha, WI). 
 
Pulmonary Haemodynamics.  All echocardiography measurements were performed 
using the same commercially available ultrasound system (Vivid Q, 3.5 MHz transducer, 
GE Healthcare, Piscataway, NJ, USA) and by the same sonographer (M.S.) with several 
years of experience (Stembridge et al. 2015).  First, the diameter of the left ventricular 
outflow tract at the level of the aortic annulus was determined from the parasternal long 
axis view.  Measurements were taken at the end of systole and the average of three 
cardiac cycles taken as the diameter of the aorta.  Then, the velocity time integral of the 
left ventricular outflow tract was obtained from an apical five-chamber view by placing a 
pulsed wave Doppler sample volume just within the aortic valve.  SV was calculated as 
the product of the velocity time integral and aortic cross-sectional area, and Q̇ was 
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obtained by multiplication with HR.  These methods have been previously described and 
validated against thermodilution and direct Fick (Christie et al. 1987). Tricuspid 
regurgitation peak velocity was measured by continuous-wave Doppler ultrasound using 
color flow imaging from the apical four-chamber view.  The pulmonary artery pressure 
gradient was then estimated from the simplified Bernoulli equation and PASP could be 
estimated by addition of right atrial pressure.  Right atrial pressure was estimated from 
collapse of the IVC during inspiration as recommended by the American Society of 
Echocardiography (Rudski et al. 2010).  The collapsibility index was calculated as the 
percentage of difference between maximal and minimal size of IVC. This method has 
been validated against right atrial pressure obtained directly by right heart catheterization 
(Yildirimturk et al. 2011).  All pulmonary haemodynamic measurements were made on 
three cardiac cycles and averaged to provide a single value.  
 
Agitated Saline Contrast Echocardiography.  The presence of PFO was determined 
under resting conditions and during a release from Valsalva maneuver using the 
technique of agitated saline contrast echocardiography (Marriott et al. 2013).  Two, 5 ml 
syringes were connected by two three-way stopcocks connected in line with each other 
and to a 22-gauge cannula placed in the antecubital vein.  One syringe contained 4 ml of 
sterile saline and the other contained 0.5 ml of air.  The two syringes were flushed back 
and forth rapidly and forcefully, creating microbubbles within the agitated saline solution 
prior to injection.  Using an apical 4-chamber view with harmonic imaging, microbubbles 
could be visualized traveling through the heart immediately after rapid injection of the 
agitated contrast.  If a negative test was identified, a Valsalva maneuver was used to 
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further assess the patency of the foramen ovale.  A PFO was identified if contrast 
appeared in the left ventricle <5 cardiac cycles after the contrast filled the right atrium.  
After all contrast injections, a minimum of 20 cardiac cycles was recorded.  In the event 
that a participant was identified as being PFO negative they were then studied for resting 
Q̇IPAVA.  An IPAVA was defined when contrast appeared in the left ventricle six or more 
cardiac cycles after the contrast appeared in the right atrium.  This technique has been 
used to investigate Q̇IPAVA in participants at SL during rest and exercise breathing room 
air or acute normobaric hypoxia (Elliott et al. 2014a; Elliott et al. 2014b; Elliott et al. 
2015; Kennedy et al. 2012; Laurie et al. 2012; Stickland et al. 2004; Tremblay et al. 
2014).  In addition, this technique has been used to investigate Q̇IPAVA at HA during rest 
(Foster et al. 2014).  A previously published scoring system was used to determine the 
severity of Q̇IPAVA based on the greatest density and spatial distribution of microbubbles 
in the left ventricle of a single cardiac cycle during the subsequent 20 cardiac cycles 
(Laurie et al. 2010).  This 0-5 scoring system assigns a ‘0’ for no microbubbles; ‘1’ for 1-
3 microbubbles; ‘2’ for 4-12 microbubbles; ‘3’ for greater than 12 microbubbles bolus; 
‘4’ for greater than 12 microbubbles heterogeneously distributed; and a ’5’ for greater 
than 12 microbubbles homogeneously distributed.  This scaling system has been 
validated for reproducibility against independent blinded observers (Laurie et al. 2010). 
 
Model of Contrast Bubble Dissolution.  Eqn. 1, derived by Solano-Altamirano and 
Goldman (2014), provides the dissolution time for a gas bubble of a given radius in a 
fluid medium.  The underlying model has three regions: a bubble, a diffusive region that 
surrounds the bubble, and a well-mixed region that surrounds the diffusive region.  The 
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bubble is spherical, and both the diffusive and the well-stirred regions are spherical 
shells.  Diffusion is the only from of transport that is explicit in the model.  Convection is 
considered indirectly and qualitatively, by using a three-region model, and the parameter 
lambda (ߣ).  When ߣ=1, the diffusion shell thickness is equal to 0, such that convection is 
the dominant transport mechanism; as ߣ approaches infinity, the model reduces to a two-
region model, wherein diffusion is the only transport mechanism [see Solano-Altamirano 
and Goldman (2014)]. 
 
t = – (ோమି ோ೚మ)(ఒିଵ)ଶ஽ఒௗ(ଵି௙)  + 
ଶ(ଶ௙ାଵ)ఊ(ோି ோ೚)(ఒିଵ)
ଷ஽ఒௗ(ଵି௙)మ௉೐  - ቄ
ସ(ଶ௙ାଵ)ఊమ(ఒିଵ)
ଷ஽ఒௗ(ଵି௙)య௉೐మ
 ∙ ln ቀ (ଵି௙)௉೐ோାଶఊ(ଵି௙)௉೐ோ೚ାଶఊቁቅ. 
Equation 1. 
 
Using this model, time to bubble dissolution (t) can be estimated as a function of initial 
bubble radius (R0) by setting the final bubble radius (R) to zero and solving the remaining 
constants as appropriate for the environmental conditions at SL and HA during rest and 
exercise.  Table 1 provides a summary of key constants and parameters used to solve Eqn 
1.  Diffusivity (D) was calculated using the Stokes-Einstein equation (Eqn 2; Kholodenko 
& Douglas, 1995) using body temperature at rest (T, 310.15 K) and exercise (311.15 K), 
a Boltzman constant (KB) of 1.38 x 10-23 J/K, the molecular radius of air (r; calculated as 
the fractional sum of the molecule radius of O2, CO2, and N2) and, finally, the average 
blood viscosity (η) of a healthy human with a haematocrit level of 46.7% at SL (2.94 cP) 
and 49.4% at HA (3.15 cP) (Hoffman, 2011; Foster et al. 2014).  
ܦ = ݇஻ܶ6ߨߟݎ 
Equation 2. 
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In Eqn 1. the external pressure (Pe) is assumed to be the sum of atmospheric pressure 
(Patm) and PASP during each condition (PASP values measured in this study were used 
for the bubble dissolution model). The f ratio in Eqn 1 is the ratio of the sum of all partial 
pressures of dissolved air in mixed venous blood (i.e. PvN2 + PvO2 + PvCO2 + PvH2O) to 
Pe.  The f ratio varies according to the difference in Patm, PASP, and the partial pressure 
of constituent gases in mixed venous blood in different environmental and physical 
conditions (see Table 1).  For example, at SL, Pe is 780 mmHg (Patm=760 mmHg and 
PASP=20 mmHg) and at rest, the partial pressure of nitrogen, oxygen, carbon dioxide 
and water vapor in mixed venous blood are 573 mmHg, 36 mmHg, 39 mmHg and 47 
mmHg respectively (George & Kinasewitz, 1983; Wagner et al. 1986), resulting in a f 
ratio of 0.891. Surface tension (γ) of the bubbles in blood is assumed to be 0.5 μatm at 
both SL and HA (Burkard, 1995).  The term ߣ is a constant used to account for the 
mixing and convection effects of the downstream compartment and has been set to a 
value of 2, similar to previous predictions involving gas emboli in circulating blood 
(Solano-Altamirano and Goldman, 2015).  Finally, d represents the Henry’s solubility 
constant and is defined by RT/KH where R is gas constant, T is body temperature during 
rest and exercise and KH is Henry’s Law constant.  Henry’s law constant for air in water 
is first temperature corrected using the van‘t Hoff equation (Atkins & de Paula, 2006) 
and determined to be 1735 l.atm/mol at rest and 1775 l.atm/mol during exercise.  Bubble 
dissolution time was calculated for bubble radii ranging in size from 0-20µm by 
completing Eqn 1 for resting conditions and exercise conditions expected at SL and HA.  
For each condition, contrast lost over time was determined by generating decay curves 
based on a random normal distribution of bubble radii which had a mean and standard 
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deviation based on two individual published reports (8.0 ± 6.5 & 19.0 ± 7.5 µm) 
(Feinstein et al. 1984; Vuille et al. 1994).  Using the dissolution time for each bubble 
within each distribution, contrast decay curves were generated to illustrate the time 
dependent instability of saline contrast in all conditions. 
 
Statistical Analysis. 
Statistical comparisons and calculations were made using statistical software (R, 
http://cran.r-project.org).  Two-way repeated-measures analyses of variance were used to 
test for differences in Q̇, PASP, SpO2, and HR between rest and multiple exercise stages 
for both SL and HA.  Bonferroni-corrected post-hoc tests were used for pair-wise 
comparisons.  Friedman’s test with Conover post-hoc test was used to test for differences 
in bubble scores between rest and exercise stages for both SL and HA.  Correlation of 
shunt scores to PASP, and Q̇ were conducted using Spearman’s rank order correlation 
coefficient.  For all tests, significance was assumed at P<0.05. 
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RESULTS  
Participant characteristics and maximal exercise data are presented in Table 2.  
Participants had normal pulmonary function and average exercise capacity.  No 
participants included in this study had a patent foramen ovale at rest or during a release 
from a Valsalva maneuver. 
Figure 1 illustrates the changes in pulmonary artery systolic pressure, heart rate, 
and cardiac output during supine cycle exercise at SL and at HA.  Resting heart rate and 
cardiac output were similar at SL and HA.  During exercise, heart rate and cardiac output 
increased with increasing exercise intensity similarly between altitudes.  PASP was 
measured in all participants at SL but at HA a high drive to breathe during exercise 
impacted image quality.  As a result, PASP was only measureable in 6 of 7 at 25% SL 
V̇O2peak and 3 of 7 at 50% SL V̇O2peak.  Resting PASP was increased at HA by 6.4 ± 2.4 
mmHg (P<0.05).  During exercise, PASP increased modestly with increasing exercise 
intensity whereas the increase in PASP at HA was substantial reaching levels of 22.8 ± 
2.4 mmHg and 26.2 ± 3.3 mmHg above SL resting values (P<0.05) during 25% and 50% 
SL V̇O2peak, respectively.  At SL, hyperoxia had no appreciable effect on PASP, heart 
rate, or Q̇.  At HA, hyperoxia trials were not conducted because there was little evidence 
of Q̇IPAVA (see below).  SpO2 was not changed by exercise at SL (SpO2: Rest = 97 ± 
0.4%; 75% SL V̇O2peak = 96 ± 0.6%) but was reduced at HA and with HA exercise 
(SpO2: Rest = 81 ± 2%; 50% SL V̇O2peak = 74 ± 2%). 
Bubble score was zero in all participants at rest at SL.  At rest at HA, with 
significantly elevated PASP and reduced SpO2, bubble score was measured to be zero in 
two participants, one in three participants, and two in two participants, with a median 
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score of 1 (Figure 2).  As expected, bubble score increased with increasing exercise 
intensity at SL with median values reaching a score of three at 75% SL V̇O2peak.  
Interestingly, hyperoxia only reduced bubble score in two participants. At HA, bubble 
scores were not increased with increasing exercise intensity.  Due to the lack of response 
with increasing exercise, hyperoxia trials were not conducted at HA.  Figure 3 shows the 
relationship between bubble score and Q̇ and PASP during exercise at SL and HA.  At SL 
a significant Spearman’s rank order correlation coefficient (rs) was found for Q̇ (rs= 
0.558, P<0.001) and PASP (rs = 0.732, P<0.001).  Such relationships were absent at HA. 
The model of saline bubble dissolution time suggested that at SL, bubbles survive 
approximately 24% longer than at HA over a bubble radii range of 8 to 19 µm, 
representing mean radii measured in previous investigations (Fig. 4a) (Feinstein et al. 
1984; Vuille et al. 1994). Based on a mean bubble radius of 8 µm from Feinstein et al 
(1984), the estimated time to dissolution was 4.2s at SL and 3.2s at HA in resting state.  
Bubbles with a mean bubble radius of 19 µm reported by Vuille et al (1994) were found 
to have an estimated time to dissolution of 49.5s at SL compared to 37.7s at HA in a 
resting physiological state.  In addition, the bubble stability is reduced under maximal 
exercise conditions at HA (Fig.4a).  As a result, exercise at HA gives the shortest 
dissolution time due to the increase in pulmonary pressure and the decreased f ratio, 
which is ~3.1 or 38.3s for mean radii proposed by Feinstein et al (1984) and Vuille et al 
(1994), respectively.  Figure 4b illustrates the decay of contrast over time where it is 
observed that time to dissolution is not only dependent upon the initial size of the bubble 
distribution but also on the altitude and physiological state (i.e. rest or exercise).  
However, the effect of the lost contrast is amplified at greater transit time (time from 
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point of contrast creation to its visualization in the left ventricle).  Hence, near maximal 
exercise, when transit time is least, the amount of contrast lost to dissolution is much less 
than in the resting state.  
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DISCUSSION  
In this study, we measured Q̇IPAVA during sub-maximal exercise at sea-level and during 
acclimatization to high-altitude (5,050m) using the technique of agitated saline contrast 
echocardiography.  The three major findings of this study are: i) the lack of change in 
Q̇IPAVA from rest to 50% of SL V̇O2Peak at HA, ii) the loss of relationship between PASP 
and Q̇ with Q̇IPAVA with increasing exercise intensity at HA, and iii) the time to 
dissolution model suggests that at near maximal exercise the destabilizing effect of HA 
on saline bubbles is an unlikely explanation for the lack of Q̇IPAVA during exercise at HA.  
These data suggest an overall lack of Q̇IPAVA during exercise following 4-7 days of HA.  
This finding is in contrast to previous reports at sea-level that show an increase in Q̇IPAVA 
during exercise in hypoxic conditions, suggesting that hypobaria or prolonged hypoxia 
may be an important regulator of Q̇IPAVA.  
Though anatomical evidence confirms the existence of IPAVA in humans, it 
remains unclear if they are actively or passively regulated.  Graded exercise at SL 
typically results in an increase in Q̇IPAVA in nearly all participants (Eldridge et al. 2004; 
Kennedy et al. 2012; Stickland et al. 2004) as does acute normobaric hypoxia (Bates et 
al. 2014; Elliott et al. 2011; Laurie et al. 2010; Lovering et al. 2008b; Norris et al. 2014), 
suggesting that the increase in Q̇ and PASP may contribute to IPAVA recruitment.  This 
mechanical hypothesis suggests that IPAVAs could serve as a pressure relief system to 
protect the pulmonary capillaries from high perfusion pressure associated with acute 
increases in cardiac output.  In this scenario, shear stress could serve as a stimulus that 
actively governs Q̇IPAVA, or Q̇IPAVA could be passively regulated through increases in 
pulmonary perfusion causing recruitment of under perfused regions of the lungs that 
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contain IPAVA.  Studies that involve a pharmacological increase in cardiac output show 
a concomitant increase in Q̇IPAVA (Bryan et al. 2012; Elliott et al. 2014a; Laurie et al. 
2012).  Our SL data are consistent with this hypothesis; we found a positive correlation 
between Q̇IPAVA and both Q̇ and PASP (Fig. 3).  The increases in Q̇IPAVA were mitigated 
by administering hyperoxia at SL (Fig. 2), which is consistent with previous data, 
providing evidence for a possible second regulatory mechanism of a humoral nature that 
responds to circulating PO2 (Duke et al. 2016; Elliott et al. 2014b; Tremblay et al. 2014).  
Interestingly, the relationships between Q̇IPAVA and Q̇ and PASP were absent following 4-
7 days of acclimatization at 5,050 m (Fig. 3); median bubble scores were 1 at rest and 
QIPAVA did not increase with exercise (Fig. 2) despite similar Q̇ compared to SL and 
substantially augmented PASP (Fig. 2).  These data are in contrast to previous work and 
suggest an added level of complexity in IPAVA regulation possibly involving pulmonary 
vascular remodeling in response to prolonged hypoxia (Stenmark et al. 2006).  
Alternatively, a serious limitation regarding the agitated saline contrast methodology 
could be involved if the stability of this contrast agent was greatly reduced at 5,050 m.  
Theoretical modeling data suggest that contrast instability is unlikely to account for the 
lack of Q̇IPAVA during exercise and a large portion of the discussion will be dedicated to 
the factors contributing to microbubble stability in the hypobaric environment.  
In interpreting our data, it is tempting to attribute the lack of Q̇IPAVA to a 
destabilizing effect associated with the low-density air within the microbubble in the HA 
environment.  Measuring Q̇IPAVA using a peripheral injection of agitated saline contrast is 
based on the assumption that as a bolus travels through the pulmonary circulation there 
are only two possible fates: (1) the bubbles travel through alveolar capillaries where 
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microbubbles dissolve and equilibrate with the alveolar gasses in the lung, or (2) the 
bubbles travel through an IPAVA and are detectable in the left atrium (Lovering & 
Goodman 2012). This oversimplified model does not account for the limited stability of 
the microbubbles within a blood vessel, which are susceptible to changes in blood gas 
concentrations, blood pressure, blood viscosity, bubble gas density, and blood gas 
solubility (Epstein & Plesset, 1950).  
In the theoretical model of bubble stability presented here, the three major factors 
contributing to the difference of dissolution time between experimental conditions are 
diffusivity, ambient pressure and saturation ratio (f).  Figure 4a illustrates that the 
decrease in diffusivity, primarily driven by a decrease in ambient pressure causes an 
overall decrease in bubble stability.  This instability at HA would be greater if not for the 
2.7% increase in blood haematocrit (7% increase in blood viscosity) expected following 
2-3 weeks of exposure at 5,050m of altitude (Foster et al. 2014).  Comparing rest and 
exercise states at SL and HA illustrates the importance the saturation factor (f) and the 
change in external pressure (Pe; Patm + PASP) have on bubble stability.  The exponential 
increase in time to dissolution with bubble radius clearly suggests that the initial bubble 
size within a bolus of agitated saline contrast is the major governor of stability.  This 
phenomenon is further illustrated in figure 4b where it is apparent that there is a much 
slower rate of contrast decay in a bolus with large mean bubble sizes.  Although the time 
dependent decay of contrast and the contrast instability caused by hypobaria are 
important factors to consider when quantifying Q̇IPAVA (Hackett et al. 2016), it seems 
unlikely that during exercise when transit time is short (~2-5s) that bubble instability 
would be of sufficient magnitude to observe no contrast in the left ventricle.  For 
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example, model data presented in Figure 4B would suggest that, at a transit time of 3s, 
the amount of contrast surviving its detection in the left ventricle would be 69.3 % at SL 
and 64.0% at HA using the bubble diameter distributions reported by Feinstein et al. 
(1984).  This difference is negligible if using the bubble diameters reported by Vuille et 
al. (1994).  Given the fact that microbubbles are nearly as stable at HA compared to SL, 
it must be assumed that there is some physiological phenomenon that arrests the 
recruitment of IPAVA at HA during exercise.  
Though this model has been shown to accurately predict bubble characteristics 
within the cardiovascular system (Solano-Altamirano & Goldman, 2014), it does not 
consider normal physiological changes in blood pressure or flow.  Once infused, the 
bubble encounters a number of different pressure environments while travelling from 
peripheral vein to its detection in the left ventricle, which could impact its stability.  We 
assumed a constant pressure equal in magnitude to the pulmonary artery systolic 
pressure.  Since high pressures decrease bubble stability, our model is a conservative 
estimate of bubble stability.  We acknowledge that the pulsatile nature of pulmonary 
arterial blood pressure could also threaten bubble stability, though previous work in an in 
vitro model determined that the oscillations in pressure were secondary to changes in 
peak pressure when determining stability (Padial et al. 1995).  Finally, it has been 
confirmed that increases in flow shorten the lifespan of a saline bubble (Yang et al. 
1971). Our model does not account for this flow effect, though it seems unlikely that the 
lack of contrast observed at HA can be attributed to flow given the similar cardiac 
outputs at SL and HA (see Figure 1).  Based upon this theoretical evidence, the lack of 
Q̇IPAVA observed in our study during exercise at HA appears to be a true physiological 
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phenomenon associated with exposure to hypobaric hypoxia or as a result of the HA 
acclimatization process. 
Our results are in contrast to our hypothesis and do not appear to be the result of 
altered saline contrast stability.  In this section, we offer some speculation into the 
physiological underpinnings for the lack of Q̇IPAVA at HA during exercise. Previous 
reports (Lovering et al. 2015) have speculated that IPAVA have greater distribution in 
the under-perfused apex of the lung, and that IPAVA may offer pressure relief in 
response to rising mean pulmonary artery pressure during hypoxic pulmonary 
vasoconstriction (HPV).  In the case of severe hypoxia, such as hypobaric exercise, 
multiple inert gas elimination technique has shown that ventilation-perfusion matching is 
impaired, possibly due to heterogeneity in the HPV response (Torre-Bueno et al. 1985) 
which may discriminately divert cardiac output away from IPAVA.  However, the 
discrepancy between acute hypoxia induced Q̇IPAVA and the lack thereof at high altitude 
(Foster et al. 2014) potentially implicates hypobaria, per se, as a regulator of IPAVA 
tone.  Evidence that the pulmonary vasculature is responsive to hypobaria independent of 
O2 status is available in the literature.  For example, Levine et al. (1988) reported 
increased pulmonary vascular resistance in sheep decompressed to 6,400 m while the 
FIO2 was increased to keep arterial PO2 at normoxic levels.  Likewise, estimates of total 
pulmonary resistance by echocardiography in humans suggests an independent effect of 
hypobaria.  In a group of 8 subjects, total pulmonary resistance (PASP/Q̇) was equal to 
4.8 ± 1.7 mmHg/l/min in normobaria but when decompressed to 5,260 m while adding 
oxygen to maintain inspired PO2, the pulmonary resistance increased to 6.2 ± 1.8 
mmHg/l/min (unpublished observations, A. Lovering, personal communication).  While it 
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is possible that hypobaria itself may directly effect pulmonary vascular tone or IPAVA 
patency, the specific mechanism is unknown.  Finally, pulmonary vascular remodeling in 
response to prolonged HPV and increased pulmonary vascular pressure may impact 
Q̇IPAVA measured following prolonged hypoxia.  Pulmonary vascular remodeling occurs 
within 3 days of high altitude exposure in animals through the proliferation of smooth 
muscle cells in normally thin-walled small pulmonary arteries and the thickening of 
media and adventitia in larger pulmonary arteries (Stenmark et al. 2006). It is not fully 
understood when pulmonary vascular remodeling begins in humans but the inability to 
reverse HPV through the administration of hyperoxia, a diagnostic test for vascular 
remodeling, suggests it can begin as early as 24 hours post exposure (Kronenberg et al. 
1971; Maggiorini et al. 2001).  While our data clearly cannot implicate any of these 
hypotheses, they do offer future avenues for research. 
We were able to study a limited number of participants (n = 7) at SL and HA, and 
this could be viewed as a limitation.  However, 50% of sea-level V̇O2peak is nearly 
maximal at 5,000 m, and is therefore a sufficiently potent stimulus which at sea level 
would evoke a substantial increase in Q̇IPAVA.  Furthermore, a post hoc power calculation 
of our result using the Wilcoxon-Mann-Whitney test suggests that our study was 
sufficiently powered (>80%) to detect a difference in bubble score at this exercise 
intensity, given our sample size.  
 
CONCLUSION 
Despite significant elevations in Q̇ and PASP during exercise at HA, Q̇IPAVA did not 
increase from resting levels.  Given that our theoretical model suggests that bubble 
stability is not sufficiently altered at HA compared to SL during the transit times of 
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interest, our findings suggest that IPAVA recruitment at HA is not similar to their 
recruitment during SL exercise or with acute normobaric hypoxia.  Using our 
experimental design, we are not able to identify the specific physiological mechanism for 
the lack of exercise-induced Q̇IPAVA at high altitude.  Future studies may consider 
manipulating the time of high altitude exposure or the level of hypobaria to help delineate 
if hypobaria or pulmonary vascular remodeling are responsible for the lack of IPAVA 
recruitment with HA exposure. 
Intrapulmonary Shunt at Altitude 
 
 
 
25
ACKNOLWEDGEMENTS 
We acknowledge Akke Bakker for contributions to data collection and Drs J.M. Solano-
Altamirano and S. Goldman for constructive critical feedback.  Financial support for this 
work was provided by APS Giles F. Filley Memorial Award (ATL), the Canada Research 
Chair program (PNA), the Natural Sciences and Engineering Research Council of Canada 
(PNA; GEF), the Petro-Canada Young innovator Award (TAD), and a MITACS 
Globalink Internship award (TAN).  This study was carried out within the framework of 
the Ev-K2-CNR Project in collaboration with the Nepal Academy of Science and 
Technology as foreseen in the Memorandum of Understanding between Nepal and Italy, 
and thanks to a contribution from the Italian National Research Council. 
 
AUTHOR CONTRIBUTIONS 
(1) Conception and design of the experiments: ATL, PNA, GEF; (2) collection, analysis 
and interpretation of data: LMB, ATL, MMT, TAD, MS, TAN, PNA, GEF (3) Drafting 
the article or revising it critically for important intellectual content: LMB, ATL, MMT, 
TAD, MS, TAN, PNA, GEF. 
 
DISCLOSURES 
None 
 
Intrapulmonary Shunt at Altitude 
 
 
 
26
REFERENCES 
Atkins P & de Paula JC (2009). Chemical Equilibrium. In: Atkins’ Physical Chemistry, 
10th edn, ed. Crowe J, Fiorillo & Hughes R, pp 244-51. Oxford University Press, Oxford. 
Basford JR (2002). The Law of Laplace and its relevance to contemporary medicine and 
rehabilitation. Arch Phys Med Rehabil 83, 1165-1170. 
Bates ML, Farrell ET, Drezdon A, Jacobson JE, Perlman SB & Eldridge MW (2014). 
Hypoxia and exercise increase the transpulmonary passage of 99mTc-labeled albumin 
particles in humans. PloS One 9, e101146. 
Bryan TL, van Diepen S, Bhutani M, Shanks M, Welsh RC & Stickland MK (2012). The 
effects of dobutamine and dopamine on intrapulmonary shunt and gas exchange in 
healthy humans. J Appl Physiol 113, 541-548. 
Christie J, Sheldahl LM, Tristani FE, Sagar KB, Ptacin MJ & Wann S (1987). 
Determination of stroke volume and cardiac output during exercise: comparison of two-
dimensional and Doppler echocardiography, Fick oximetry, and thermodilution. 
Circulation 76, 539-547. 
Cohen RE, Cvitas, T, Frey JG, Holstrom Bertil, Kuchitsu K, Marquardt R, Mills I, Pavese 
F, Quack M, Stohner J, Strauss HL, Takami M, Thor AJ (2007). Chapter 1. Physical 
quantities and units. In: Quantities, Units and Symbols in Physical Chemistry, 3rd edn, ed. 
Cohen RE, Cvitas, T, Frey JG, Holstrom Bertil, Kuchitsu K, Marquardt R, Mills I, Pavese 
F, Quack M, Stohner J, Strauss HL, Takami M, Thor AJ, pp 1-7. Royal Society of 
Chemistry, Cambridge. 
Intrapulmonary Shunt at Altitude 
 
 
 
27
Duke JW, Davis JT, Ryan BJ, Elliott JE, Beasley KM, Hawn JA, Byrnes WC, Lovering 
AT (2016). Decreased arterial PO2, not O2 content, increases blood flow through 
intrapulmonary arteriovenous anastomoses at rest. J Physiol 594, 4981–96. 
Eldridge MW, Dempsey JA, Haverkamp HC, Lovering AT, Hokanson JS (2004). 
Exercise-induced intrapulmonary arteriovenous shunting in healthy humans. J Appl 
Physiol 97, 797-805. 
Elliott JE, Choi Y, Laurie SS, Yang X, Gladstone IM, Lovering AT (2011). Effect of 
initial gas bubble composition on detection of inducible intrapulmonary arteriovenous 
shunt during exercise in normoxia, hypoxia, or hyperoxia. J Appl Physiol 110, 35-45. 
Elliott JE, Duke JW, Hawn JA, Halliwill JR, Lovering AT (2014a). Increased cardiac 
output, not pulmonary artery systolic pressure, increases intrapulmonary shunt in healthy 
humans breathing room air and 40% O2. J Physiol 592, 4537-4553. 
Elliott JE, Friedman JM, Futral JE, Goodman RD, Lovering AT (2014b). Sildenafil, 
nifedipine and acetazolamide do not allow for blood flow through intrapulmonary 
arteriovenous anastomoses during exercise while breathing 100% oxygen. Exp Physiol 
99, 1636-1647. 
Elliott JE, Laurie SS, Kern JP, Beasley KM, Goodman RD, Kayser, B, Subdhi AW, 
Roach RC, Lovering AT (2015). AltitudeOmics: impaired pulmonary gas exchange 
efficiency and blunted ventilatory acclimatization in humans with patent foramen ovale 
after 16 days at 5,260 m. J Appl Physiol 118, 1100-1112. 
Intrapulmonary Shunt at Altitude 
 
 
 
28
Elliott JE, Nigam SM, Laurie SS, Beasley KM, Goodman RD, Hawn JA, Gladstone IM, 
Chesnutt MS, Lovering AT (2013). Prevalence of left heart contrast in healthy, young, 
asymptomatic humans at rest breathing room air. Respir Physiol Neurobiol 188, 71-78. 
Epstein PS, Plesset MS (1950). On the Stability of Gas Bubbles in Liquid -Gas Solutions. 
J Chem Phys 18, 1505-1509. 
Feinstein SB, Ten Cate FJ, Zwehl W, Ong K, Maurer, G, Tei C, Shah PM, Meerbaum S, 
Corday E (1984a). Two-dimensional contrast echocardiography. I. In vitro development 
and quantitative analysis of echo contrast agents. J Am Coll Cardiol 3, 14-20.  
Feinstein SB, Shah PM, Bing RJ, Meerbaum S, Corday E, Chang B, Santillan G, 
Fujibayashi Y (1984b). Microbubble dynamics visualized in the intact capillary 
circulation. J Am Coll Cardiol 4, 595-600. 
Fenn WO, Rahn H, Otis AB (1946).  A theoretical study of the composition of the 
alveolar air at altitude.  Am J Physiol 146, 637-53. 
Foster GE, Ainslie PN, Stembridge M, Day TA, Bakker A, Lucas SJ, Lewis NC, 
MacLeod DB, Lovering AT (2014). Resting pulmonary haemodynamics and shunting: a 
comparison of sea-level inhabitants to high altitude Sherpas. J Physiol 592, 1397-1409. 
Gale GE, Torre-Bueno JR, Moon RE, Saltzman HA & Wagner PD (1985). Ventilation-
perfusion inequality in normal humans during exercise at sea level and simulated altitude. 
J Appl Physiol 58, 978–988. 
Intrapulmonary Shunt at Altitude 
 
 
 
29
George RB, Kinasewitz GT (1983). Alveolar ventilation, gas exchange, oxygen delivery, 
and acid-base physiology. In: Chest Medicine: Essentials of Pulmonary and Critical Care 
Medicine, 5th edn. ed. George RB, Light RW, Matthay MA, Matthay RA, pp 39-54. 
Lippincott Williams & Wilkins, Philadelphia. 
Hackett HK, Boulet LM, Dominelli PB, Foster GE (2016). A methodological approach 
for quantifying and characterizing the stability of agitated saline contrast: implications for 
quantifying intrapulmonary shunt. J Appl 121, 568-76. 
Hoffman JI (2011). Pulmonary vascular resistance and viscosity: the forgotten factor. 
Pediatr Cardiol 32, 557-561. 
Hopkins SR, Belzberg AS, Wiggs BR, McKenzie DC (1996). Pulmonary transit time and 
diffusion limitation during heavy exercise in athletes. Respir Physiol 103, 67-73. 
Imray CH, Pattinson KT, Myers S, Chan CW, Hoar H, Brearey S, Collins P, Wright AD, 
Birmingham Medical Research Expeditionary Society (2008). Intrapulmonary and 
intracardiac shunting with exercise at altitude. Wilderness Environ Med 19, 199-204. 
Kennedy JM, Foster GE, Koehle MS, Potts JE, Sandor GG, Potts MT, Houghton KM, 
Henderson WR, Sheel AW (2012). Exercise-induced intrapulmonary arteriovenous shunt 
in healthy women. Respir Physiol Neurobiol 181, 8-13. 
Kholodenko AL, Douglas JF (1995). Generalized Stokes-Einstein equation for spherical 
particle suspensions. Phys Rev 51, 1081-90. 
Intrapulmonary Shunt at Altitude 
 
 
 
30
Kronenberg RS, Safar P, Lee J, Wright F, Noble W, Wahrenbrock E, Hickey R, Nemoto 
E & Severinghaus JW (1971). Pulmonary artery pressure and alveolar gas exchange in 
man during acclimatization to 12,470 ft. J Clin Invest 50, 827–837. 
Laurie SS, Elliott JE, Goodman RD, Lovering AT (2012). Catecholamine-induced 
opening of intrapulmonary arteriovenous anastomoses in healthy humans at rest. J Appl 
Physiol 113, 1213-1222. 
Laurie SS, Yang X, Elliott JE, Beasley KM, Lovering AT (2010). Hypoxia-induced 
intrapulmonary arteriovenous shunting at rest in healthy humans. J Appl Physiol 109, 
1072-1079. 
Lewis NC, Bailey DM, Dumanoir GR, Messinger L, Lucas SJ, Cotter JD, Donnelly J, 
McEneny J, Young IS, Stembridge M, Burgess KR, Basnet AS, Ainslie PN (2014). 
Conduit artery structure and function in lowlanders and native highlanders: relationships 
with oxidative stress and role of sympathoexcitation. J Physiol 592, 1009-1024. 
Levine BD, Kubo K, Kobayashi T, Fukushima M, Shibamoto T & Ueda G (1988). Role 
of barometric pressure in pulmonary fluid balance and oxygen transport. J Appl Physiol 
64, 419–428. 
Lovering AT, Stickland MK, Amann M, Murphy JC, O'Brien MJ, Hokanson JS, Eldridge 
MW (2008a). Hyperoxia prevents exercise-induced intrapulmonary arteriovenous shunt 
in healthy humans. J Physiol 586, 4559-4565. 
Intrapulmonary Shunt at Altitude 
 
 
 
31
Lovering AT, Romer LM, Haverkamp HC, Pegelow DF, Hokanson JS, Eldridge MW 
(2008b). Intrapulmonary shunting and pulmonary gas exchange during normoxic and 
hypoxic exercise in healthy humans. J Appl Physiol 104, 1418-1425. 
Lovering AT, Stickland MK, Kelso AJ, Eldridge MW (2007). Direct demonstration of 
25- and 50-microm arteriovenous pathways in healthy human and baboon lungs. Am J 
Physiol Heart Circ Physiol 292, H1777-H1781. 
Lovering AT, Goodman R (2012). Detection of intracardiac and intrapulmonary shunts at 
rest and during exercise using saline contrast echocardiography. In: Applied Aspects of 
Ultrasonography in Humans, 1st edn. ed. Ainslie PN, pp 159-74. InTec. 
Maggiorini M, Mélot C, Pierre S, Pfeiffer F, Greve I, Sartori C, Lepori M, Hauser M, 
Scherrer U & Naeije R (2001). High-Altitude Pulmonary Edema Is Initially Caused by an 
Increase in Capillary Pressure. Circulation 103, 2078–2083. 
Marriott K, Manins V, Forshaw A, Wright J, Pascoe R. Detection of right-to-left atrial 
communication using agitated saline contrast imaging: experience with 1162 patients and 
recommendations for echocardiography (2013). J Am Soc Echocardiogr 26, 96-102.  
Miller MR, Hankinson J, Brusasco V, Burgos F, Casaburi R, Coates A, Crapo R, Enright 
P, van der Grinten CPM, Gustafsson P, Jensen R, Johnson DC, MacIntyre N, McKay R, 
Navajas D, Pedersen OF, Pellegrino R, Viegi, G. Wanger J (2005). Standardisation of 
spirometry. Eur Respir J 26, 319-338. 
Intrapulmonary Shunt at Altitude 
 
 
 
32
Norris HC, Mangum TS, Duke JW, Straley TB, Hawn JA, Goodman RD, Lovering AT 
(2014). Exercise- and hypoxia-induced blood flow through intrapulmonary arteriovenous 
anastomoses is reduced in older adults. J Appl Physiol 116, 1324-1333. 
Padial LR, Chen MH, Vuille C, Guerrero JL, Weyman AE, Picard MH (1995). Pulsatile 
pressure affects the disappearance of echocardiographic contrast agents. J Am Soc 
Echocardiogr 8, 285-292. 
Quay SC. (1995). Gaseous ultrasound contrast media. US Patent 5,409,688. 
Rudski LG, Lai WW, Afilalo J, Hua L, Handschumacher MD, Chandrasekaran K, 
Solomon SD, Louie EK, Schiller NB (2010). Guidelines for the echocardiographic 
assessment of the right heart in adults: a report from the American Society of 
Echocardiography. J Am Soc Echocardiogr 23, 685-713, quiz 786-8. 
Sander R (2015). Compilation of Henry's law constants (version 4.0) for water as solvent. 
Atmos Chem Phys 15, 4399-4981. 
Smirl JD, Lucas SJ, Lewis NC, duManoir GR, Smith KJ, Bakker A, Basnyat AS, Ainslie 
PN (2014). Cerebral pressure-flow relationship in lowlanders and natives at high altitude. 
J Cereb.Blood Flow Metab 34, 248-257. 
Smith KJ, Macleod D, Willie CK, Lewis NC, Hoiland RL, Ikeda K, Tymko MM, 
Donnelly J, Day TA, MacLeod N, Lucas SJ, Ainslie PN (2014). Influence of high altitude 
on cerebral blood flow and fuel utilization during exercise and recovery. J Physiol 592, 
5507-27. 
Intrapulmonary Shunt at Altitude 
 
 
 
33
Solano-Altamirano JM, Goldman S (2014). The lifetimes of small arterial gas emboli, 
and their possible connection to Inner Ear Decompression Sickness. Math Biosci 252, 27-
35. 
Solano-Altamirano JM, Goldman S (2015). Decompression sickness in breath-hold 
diving, and its probable connection to the growth and dissolution of small arterial gas 
emboli. Math Biosci 262, 1-9. 
Stembridge M, Ainslie PN, Hughes MG, Stöhr EJ, Cotter JD, Tymko MM, Day TA, 
Bakker A, Shave R (2015). Impaired myocardial function does not explain reduced left 
ventricular filling and stroke volume at rest or during exercise at high altitude. J Appl 
Physiol 119, 1219-1227. 
Stenmark KR, Fagan KA, Frid MG (2006). Hypoxia-induced pulmonary vascular 
remodeling: cellular and molecular mechanisms. Circ Res 99, 675-691. 
Stickland MK, Welsh RC, Haykowsky MJ, Petersen SR, Anderson WD, Taylor DA, 
Bouffard M, Jones RL (2004). Intra-pulmonary shunt and pulmonary gas exchange 
during exercise in humans. J Physiol 561, 321-329. 
Subudhi AW, Fan JL, Evero O, Bourdillon N, Kayser B, Julian CG, Lovering AT, Roach 
RC (2014). AltitudeOmics: effect of ascent and acclimatization to 5260 m on regional 
cerebral oxygen delivery. Exp Physiol 99, 772-781. 
Tobin CE (1966). Arteriovenous shunts in the peripheral pulmonary circulation in the 
human lung. Thorax 21, 197-204. 
Intrapulmonary Shunt at Altitude 
 
 
 
34
Torre-Bueno JR, Wagner PD, Saltzman HA, Gale GE & Moon RE (1985). Diffusion 
limitation in normal humans during exercise at sea level and simulated altitude. J Appl 
Physiol 58, 989–995. 
Tremblay JC, Lovering AT, Ainslie PN, Stembridge M, Burgess KR, Bakker A, 
Donnelly J, Lucas SJ, Lewis NC, Dominelli PB, Henderson WR, Dominelli GS, Sheel 
AW, Foster GE (2014). Hypoxia, not pulmonary vascular pressure induces blood flow 
through intrapulmonary arteriovenous anastomoses. J Physiol 593, 723-737. 
Van Liew HD & Burkard ME (1995). Bubbles in circulating blood: stabilization and 
simulations of cyclic changes of size and content. J Appl Physiol 79, 1379-85. 
Vuille C, Nidorf M, Morrissey RL, Newell JB, Weyman AE, Picard MH (1994). Effect 
of static pressure on the disappearance rate of specific echocardiographic contrast agents. 
J Am Soc Echocardiogr 7, 347-354. 
Wagner PD, Gale GE, Moon RE, Torre-Bueno JR, Stolp BW, Saltzman HA (1986). 
Pulmonary gas exchange in humans exercising at sea level and simulated altitude. J Appl 
Physiol 61, 260-270. 
Wagner WW, Latham LP & Capen RL (1979). Capillary recruitment during airway 
hypoxia: role of pulmonary artery pressure. J Appl Physiol 47, 383–387. 
Willie CK, MacLeod DB, Smith KJ, Lewis NC, Foster GE, Ikeda K, Hoiland RL, Ainslie 
PN (2015). The contribution of arterial blood gases in cerebral blood flow regulation and 
fuel utilization in man at high altitude. J Cereb Blood Flow Metab 35, 873-881. 
Intrapulmonary Shunt at Altitude 
 
 
 
35
Willie CK, Smith KJ, Day TA, Ray LA, Lewis NC, Bakker A, Macleod DB, Ainslie PN 
(2014). Regional cerebral blood flow in humans at high altitude: gradual ascent and 2 wk 
at 5,050 m. J Appl Physiol 116, 905-910. 
Yang WJ, Echigo R, Wotton DR, Hwang JB (1971). Experimental studies of the 
dissolution of gas bubbles in whole blood and plasma. II. Moving bubbles or liquids. J 
Biomech 4, 283-288. 
Yildirimturk O, Tayyareci Y, Erdim R, Ozen E, Yurdakul S, Aytekin V, Demiroglu IC, 
Aytekin S (2011). Assessment of right atrial pressure using echocardiography and 
correlation with catheterization. J Clin Ultrasound 39, 337-343. 
 
Intrapulmonary Shunt at Altitude 
 
 
 
36
TABLES 
Table 1. Summary of mixed venous blood gases and model constants used to solve 
Eqn 1. 
 
 Sea Level High Altitude 
 Rest Exercise Rest Exercise
Patm, mmHg 760 760 413 413 
PASP, mmHg 20 26 34 52 
Pe, mmHg 780 786 447 465 
PvN2, mmHg 573 573 278 278 
PvO2, mmHg 36 19 27 13 
PvCO2, mmHg 39 63 34 42 
PvH2O, mmHg 47 51 47 51 
f 0.891 0.898 0.864 0.826 
D, μm2/s 683.3 686.8 637.8 641.0 
d  0.015 0.015 0.015 0.014 
 
Definition of abbreviations: Patm, atmospheric pressure; PASP, pulmonary artery systolic 
pressure; Pe, external pressure; PvN2, mixed venous partial pressure of nitrogen; PvO2, 
mixed venous partial pressure of oxygen; PvCO2, mixed venous partial pressure of 
carbon dioxide; PvH2O, water vapour pressure in mixed venous environment; f, ratio of 
the sum of all mixed venous gases and the ambient pressure; D, diffusivity; d, Henry’s 
solubility constant for an ideal gas.  Patm and PASP are measured in the current study 
while the partial pressure of mixed venous nitrogen, oxygen, and carbon dioxide are 
based on published reports at similar altitudes (George & Kinasewitz, 2005; Fenn et al. 
1946; Wagner et al. 1986).  
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Table 2. Participant characteristics, resting pulmonary function and maximal 
exercise data measured at SL. 
 
Variable MEAN ± SD
Age, yr 33 ± 8 
Height, m 1.76 ± 0.08 
Weight, kg 81.7 ± 12.5 
BMI, kg m-2 26.4 ± 2.9 
FVC, l  
(% predicted) 
5.0 ± 0.9  
(99 ± 11) 
FEV1.0, l  
(% predicted) 
4.14 ± 0.71  
(105 ± 13) 
FEV1.0/FVC, %  
(% predicted) 
82 ± 2  
(106 ± 3) 
V̇O2peak, ml kg-1 min-1 45 ± 9 
Power at V̇O2peak, W 292 ± 66 
Maximal HR, bpm 173 ± 17 
 
Data are mean ± SD. Maximal exercise data is measured at sea level. Definition of 
abbreviations: BMI, body mass index; FVC, forced vital capacity; FEV1.0, forced 
expiratory volume in one second; V̇O2peak, peak oxygen consumption; HR, heart rate.  
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FIGURE LEGENDS 
 
Figure 1: Pulmonary artery systolic pressure (PASP; A), heart rate (B), and cardiac 
output (Q̇; C) at rest and during supine cycle exercise at sea level and 5,050m. Data are 
means ± SEM.  *P<0.05 compared to rest. P<0.05 compared to sea level. Definitions of 
abbreviations: % SL V̇O2peak: percent of peak oxygen consumption determined during a 
maximal supine cycle exercise test conducted at sea level.  
 
Figure 2: The bubble score at rest, during exercise, and with hyperoxia while at sea-level 
(A) and high altitude (B). Individual participant bubble scores are provided at each stage 
of exercise. The line indicates the median value. *P<0.05 compared to rest. Definition of 
abbreviations: % SL V̇O2peak: percent of peak oxygen consumption determined during a 
maximal supine cycle exercise test conducted at sea level. 
 
Figure 3. The relationship between bubble score and cardiac output (A) and pulmonary 
artery systolic pressure (PASP; B) at sea level and high altitude. At sea level, a 
significant spearman rank order coefficient was found relating bubble scores with cardiac 
output and PASP. At high altitude this correlation was lost. Definition of abbreviations: 
SL: sea level; HA: high altitude; rs = Spearman rank order correlation coefficient; PASP: 
pulmonary artery systolic pressure. 
 
Figure 4. Theoretical model of microbubble stability. A. The time to bubble dissolution 
as a function of bubble radius in blood during rest and exercise at sea level and following 
4-7 days of acclimatization to 5,050m. B. The estimated percent of contrast conserved 
within a bolus of agitated saline contrast over time for bubbles in the pulmonary 
circulation during rest and exercise at sea level and following 4-7 days of acclimatization 
at 5,050 m. Data are calculated based on the curves presented in panel A and a random 
normal bubble diameter distribution based on published reports of bubble diameter in 
agitated saline made at sea-level (Feinstein et al. 1984; Vuille et al. 1994). Hatched box 
represents the range of expected transit times from rest (~9.3s) to exercise (~3.0s) 
(Hopkins et al. 1996).  
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